Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (231-240 of 271) with videos related to

Pageof 28
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Testicular cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain MetastasesBetul Gok Yavuz, Peng Li, Jose A Ovando-Ricardez, et al.
Cancer Research|August 16, 2017
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell CarcinomasMianen Sun, Pan Tong, Wen Kong, et al.
Cancer Cell|February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerDaniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Angiogenesis|December 2, 2022
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergyPatrycja Nowak-Sliwinska, Judy R van Beijnum, Christian J Griffioen, et al.
Nature Communications|November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinomaMatthew T Campbell, Surena F Matin, Alda L Tam, et al.
The Journal of Clinical Investigation|April 15, 2024
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesisMelissa M Wolf, Matthew Z Madden, Emily N Arner, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and ResistanceMostafa I H Ali, Zeynep Feyza Akpinar, Jose A Ovando-Ricardez, et al.
European Urology|March 1, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic ModelChad Tang, Aaron Seo, Alexander D Sherry, et al.
Pageof 28

Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Testicular cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain MetastasesBetul Gok Yavuz, Peng Li, Jose A Ovando-Ricardez, et al.
Cancer Research|August 16, 2017
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell CarcinomasMianen Sun, Pan Tong, Wen Kong, et al.
Cancer Cell|February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerDaniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Angiogenesis|December 2, 2022
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergyPatrycja Nowak-Sliwinska, Judy R van Beijnum, Christian J Griffioen, et al.
Nature Communications|November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinomaMatthew T Campbell, Surena F Matin, Alda L Tam, et al.
The Journal of Clinical Investigation|April 15, 2024
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesisMelissa M Wolf, Matthew Z Madden, Emily N Arner, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and ResistanceMostafa I H Ali, Zeynep Feyza Akpinar, Jose A Ovando-Ricardez, et al.
European Urology|March 1, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic ModelChad Tang, Aaron Seo, Alexander D Sherry, et al.
Pageof 28